These findings are consistent with those of Abe et al. [34], who reported that NT-proBNP was associated with both myeloma-related renal dysfunction and left ventricular diastolic dysfunction—highlighting NT-proBNP’s potential as a composite marker for both cardiac and renal impairment in MM. This evidence concerns the gene NPPB and Abnormal renal physiology.